Natco Pharma Ltd Quarterly Results

Gross Sales

1,221

474.8

1,371.1

1,362.6

1,068.3

Excise Duty

0

0

0

0

0

Net Sales

1,221

474.8

1,371.1

1,362.6

1,068.3

Other Operating Income

0

0

0

0

0

Other Income

66.3

176.3

63.8

48.1

42

Total Income

1,287.3

651.1

1,434.9

1,410.7

1,110.3

Total Expenditure

672.9

436

566.8

557.8

571

PBIDT

614.4

215.1

868.1

852.9

539.3

Interest

10.2

4.4

4.1

5.2

6.2

PBDT

604.2

210.7

864

847.7

533.1

Depreciation

98.3

47

45.8

44.1

55.5

Minority Interest Before NP

0

0

0

0

0

Tax

106.4

33.5

154.1

143.6

90.3

Deferred Tax

-6.5

-2.2

-12.4

-8.5

1

Reported Profit After Tax

406

132.4

676.5

668.5

386.3

Minority Interest After NP

-0.6

-0.6

-0.8

0

0

Net Profit after Minority Interest

406.6

133

677.3

668.5

386.3

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

406.6

133

677.3

668.5

386.3

EPS (Unit Curr.)

22.7

7.43

37.81

37.32

21.56

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

75

75

150

62.5

Equity

35.8

35.8

35.8

35.8

35.8

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

50.31

45.3

63.31

62.59

50.48

PBDTM(%)

49.48

44.37

63.01

62.21

49.9

PATM(%)

33.25

27.88

49.33

49.06

36.16